Keywords: Nycomed, Roche, Takeda, Bonviva, Osteoporosis, Asia-Pacific markets

Nycomed to market Roche's osteo drug Bonviva in key Asia-Pacific markets

Article | 16 June 2011

Print This

Independent Swiss drugmaker Nycomed says that it has completed the transfer of marketing authorization approvals in a number of key ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in